CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.

Authors:
Narváez-Pérez LF; Paz-Bermúdez F; Avalos-Fuentes JA; Campos-Romo A; Florán-Garduño B and 1 more

Journal:
Gene Ther

Publication Year: 2023

DOI:
10.1038/s41434-023-00414-0

PMCID:
PMC10788271

PMID:
37542151

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Gene Ther

Abbreviation: Gene Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumati…
Thampi P; Seabaugh KA; Pezzanite LM and 6 more (2023) - Transparency Score: 3/6
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and …
Saleh S; Dabbous O; Sullivan SD and 7 more (2023) - Transparency Score: 3/6
Immunobiology of a rationally-designed AAV2 capsid following intravitreal delivery in mice.
Whitehead M; Sage A; Burgoyne T and 3 more (2023) - Transparency Score: 3/6
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cel…
Nieuwenhuis B; Laperrousaz E; Tribble JR and 5 more (2023) - Transparency Score: 3/6
rAAV-PHP.B escapes the mouse eye and causes lethality whereas rAAV9 can transduce aniridic corneal …
Mirjalili Mohanna SZ; Korecki AJ; Simpson EM. (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work received financial support from Pfizer Through its independent medical grants program (JS)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025